- Home
- NAMS vs RYN Comparison
NAMS vs RYN Comparison
Compare NAMS & RYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NAMS | RYN |
|---|---|---|
| Founded | 2019 | 1926 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NAMS | RYN |
|---|---|---|
| Price | $32.21 | $24.34 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 4 |
| Target Price | ★ $46.40 | $27.00 |
| AVG Volume (30 Days) | 764.0K | ★ 1.8M |
| Earning Date | 02-25-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 11.72% |
| EPS Growth | N/A | ★ 373.89 |
| EPS | N/A | ★ 5.07 |
| Revenue | $35,243,000.00 | ★ $1,293,371,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $10.46 | N/A |
| P/E Ratio | ★ N/A | $4.87 |
| Revenue Growth | 4.91 | ★ 60.70 |
| 52 Week Low | $14.06 | $21.06 |
| 52 Week High | $42.00 | $28.31 |
Technical Indicators
Market Signals| Indicator | NAMS | RYN |
|---|---|---|
| Relative Strength Index (RSI) | 39.50 | 66.52 |
| Support Level | $30.97 | $22.93 |
| Resistance Level | $32.45 | $24.78 |
| Average True Range (ATR) | 1.64 | 0.62 |
| MACD | -0.24 | 0.29 |
| Stochastic Oscillator | 29.97 | 86.70 |
Price Performance
Historical ComparisonAbout NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
About RYN Rayonier Inc. REIT
Rayonier owns and manages over 2 million acres of timberland in the United States. It is one the largest private landowners in North America. Rayonier is structured as a real estate investment trust and is not required to pay federal income taxes on earnings generated by timber harvest activities.